Centene (CNC) vs Humana (HUM)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.
Summary
Centene (CNC) has outperformed Humana (HUM) over the past year, gaining 74.7% versus a gain of 71.7%. Over five years, HUM leads with a -9.0% price change compared with -13.7% for CNC. Humana is the larger company by market cap ($46.84 billion vs $31.58 billion), about 1.5 times the size, while Centene is growing revenue faster (+19.4% vs +10.1%).
On valuation, Centene trades at a lower forward P/E (11.4x vs 21.1x for Humana). Humana pays a dividend yielding 0.91%, while Centene does not currently pay one. Humana converts more of its revenue into profit, with a net margin of 0.9% versus -3.4%.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CNC | HUM |
|---|---|---|
| Share price | $63.78 | $390.00 |
| Market cap | $31.58B | $46.84B |
| 1-day change | -2.74% | +2.63% |
| YTD return | +54.99% | +52.27% |
| 1-year return | +74.74% | +71.73% |
| 5-year return | -13.69% | -8.98% |
| P/E ratio (TTM) | 21.92 | 38.05 |
| Forward P/E | 11.45 | 21.06 |
| EPS (TTM) | $2.91 | $10.25 |
| Dividend yield | 0.00% | 0.91% |
| Annual dividend | $0.00 | $3.54 |
| Revenue (latest FY) | $194.78B | $129.66B |
| Revenue growth (YoY) | +19.44% | +10.11% |
| Net income (latest FY) | $-6.67B | $1.19B |
| Gross margin | 7.30% | — |
| Operating margin | -3.91% | 2.09% |
| Net margin | -3.43% | 0.92% |
| 52-week high | $78.08 | $462.87 |
| 52-week low | $31.63 | $163.11 |
| Distance from 52-week high | -18.31% | -15.74% |
| Analyst consensus | buy | buy |
| Avg. price target upside | +19.33% | +30.98% |
| Average volume | 5.09M | 1.46M |
| Shares outstanding | 495.07M | 120.10M |
| Employees | 61,100 | 67,060 |
| Sector | Health Care | Health Care |
| Industry | Medical Specialities | Medical Specialities |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Humana trades at a higher earnings multiple (38.0x vs 21.9x trailing P/E).
- Centene grew revenue faster in its latest fiscal year (+19.44% vs +10.11%).
About Centene
CNC stock →Centene Corporation operates as a managed care company that provides programs and services to under-insured families, and commercial organizations in the United States. It operates through four segments: Medicaid, Medicare, Commercial, and Other.
Health Care · Medical Specialities · 61,100 employees
About Humana
HUM stock →Humana Inc. provides medical and specialty insurance products in the United States.
Health Care · Medical Specialities · 67,060 employees
CNC vs HUM FAQ
Which is bigger, Centene or Humana?
Humana (HUM) is larger, with a market capitalization of $46.84B compared with $31.58B for Centene (CNC).
Which stock has performed better over the past year, CNC or HUM?
CNC returned +74.74% over the past 12 months, compared with +71.73% for HUM (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CNC or HUM?
CNC has the lower trailing P/E at 21.9, versus 38.0 for HUM. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Centene or Humana?
Humana pays a dividend yielding 0.91%, while Centene does not currently pay a regular dividend.
Are Centene and Humana in the same industry?
Yes. Both are classified in the Medical Specialities industry within the Health Care sector.